[go: up one dir, main page]

DE69728857T2 - Feste arzneimittel enthaltend trehalose - Google Patents

Feste arzneimittel enthaltend trehalose Download PDF

Info

Publication number
DE69728857T2
DE69728857T2 DE69728857T DE69728857T DE69728857T2 DE 69728857 T2 DE69728857 T2 DE 69728857T2 DE 69728857 T DE69728857 T DE 69728857T DE 69728857 T DE69728857 T DE 69728857T DE 69728857 T2 DE69728857 T2 DE 69728857T2
Authority
DE
Germany
Prior art keywords
amount
active agent
trehalose
medicaments containing
microgranules
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69728857T
Other languages
English (en)
Other versions
DE69728857D1 (de
DE69728857T3 (de
Inventor
Joseph Roser
Julian Blair
Camilo Colaco
Henry Hatley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Quadrant Drug Delivery Ltd
Original Assignee
Quadrant Drug Delivery Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27083298&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69728857(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/599,273 external-priority patent/US5958455A/en
Priority claimed from US08/599,277 external-priority patent/US5762961A/en
Application filed by Quadrant Drug Delivery Ltd filed Critical Quadrant Drug Delivery Ltd
Publication of DE69728857D1 publication Critical patent/DE69728857D1/de
Application granted granted Critical
Publication of DE69728857T2 publication Critical patent/DE69728857T2/de
Publication of DE69728857T3 publication Critical patent/DE69728857T3/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
DE69728857T 1996-02-09 1997-02-10 Feste arzneimittel enthaltend trehalose Expired - Fee Related DE69728857T3 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US599277 1996-02-09
US08/599,273 US5958455A (en) 1996-02-09 1996-02-09 Oral solid dosage forms, methods of making same and compositions thereof
US599273 1996-02-09
US08/599,277 US5762961A (en) 1996-02-09 1996-02-09 Rapidly soluble oral solid dosage forms, methods of making same, and compositions thereof
PCT/GB1997/000367 WO1997028788A1 (en) 1996-02-09 1997-02-10 Solid formulations containing trehalose

Publications (3)

Publication Number Publication Date
DE69728857D1 DE69728857D1 (de) 2004-06-03
DE69728857T2 true DE69728857T2 (de) 2005-04-21
DE69728857T3 DE69728857T3 (de) 2010-02-18

Family

ID=27083298

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69728857T Expired - Fee Related DE69728857T3 (de) 1996-02-09 1997-02-10 Feste arzneimittel enthaltend trehalose

Country Status (9)

Country Link
EP (1) EP0879048B2 (de)
JP (1) JP2000505801A (de)
CN (1) CN1213299A (de)
AT (1) ATE265205T1 (de)
AU (1) AU1729297A (de)
BR (1) BR9714509A (de)
CA (1) CA2245708C (de)
DE (1) DE69728857T3 (de)
WO (1) WO1997028788A1 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030013740A1 (en) * 1998-03-27 2003-01-16 Martin P. Redmon Stable dosage forms of fluoxetine and its enantiomers
US6455096B1 (en) 1998-04-28 2002-09-24 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Hard candy with a relatively-high moisture and hardness, and process of the same
CN1185013C (zh) 1998-07-15 2005-01-19 旭化成株式会社 赋形剂
WO2000013680A2 (en) * 1998-09-09 2000-03-16 Quadrant Holdings Cambridge Limited Filamentous amorphous carbohydrate compositions and therapeutic delivery vehicles comprising them
GB9904911D0 (en) * 1999-03-03 1999-04-28 Scherer Ltd R P Pharmaceutical compositions
GB2353933A (en) * 1999-09-09 2001-03-14 British Sugar Plc Compositions comprising trehalose for forming tablets
FR2798289B1 (fr) 1999-09-15 2004-12-31 Cll Pharma Formes galeniques a delitement rapide en bouche et leur procede de preparation
JP4493769B2 (ja) * 1999-12-21 2010-06-30 旭化成ケミカルズ株式会社 球形顆粒
FR2810258B1 (fr) * 2000-06-15 2004-11-12 Antony Guyader Gels d'electrophorese secs et rehydratables caracterises par une conservation longue duree
US7575761B2 (en) 2000-06-30 2009-08-18 Novartis Pharma Ag Spray drying process control of drying kinetics
JP2002034472A (ja) * 2000-07-21 2002-02-05 Kanebo Ltd 温熱付与剤及びそれを用いた食品並びに加水食品の製法
EP1992335A1 (de) 2001-11-01 2008-11-19 Nektar Therapeutics Sprühtrocknungsverfahren und Zusammensetzungen dafür
US9339459B2 (en) 2003-04-24 2016-05-17 Nektar Therapeutics Particulate materials
EP1460080A1 (de) * 2003-03-21 2004-09-22 Cargill Incorporated Direkt komprimierbare Trehalose in fester Form
JP2007131587A (ja) * 2005-11-11 2007-05-31 Activas Pharma:Kk キノリノン誘導体を有効成分とする医薬組成物、及びその製造方法
CA2642952C (en) 2006-02-20 2014-09-02 Chugai Seiyaku Kabushiki Kaisha Pharmaceutical composition comprising oseltamivir phosphate
WO2009091017A1 (ja) * 2008-01-18 2009-07-23 Asahi Kasei Pharma Corporation 安定な医薬組成物
US8784884B2 (en) 2009-09-17 2014-07-22 Stephen Perrett Pancreatic enzyme compositions and methods for treating pancreatitis and pancreatic insufficiency
GB201012539D0 (en) 2010-07-27 2010-09-08 Savantium Ltd Nutritional compositions
US8524662B2 (en) 2010-12-28 2013-09-03 Depuy Mitek, Llc Compositions and methods for treating joints
US8455436B2 (en) 2010-12-28 2013-06-04 Depuy Mitek, Llc Compositions and methods for treating joints
US8398611B2 (en) 2010-12-28 2013-03-19 Depuy Mitek, Inc. Compositions and methods for treating joints
US8623839B2 (en) 2011-06-30 2014-01-07 Depuy Mitek, Llc Compositions and methods for stabilized polysaccharide formulations
US9682099B2 (en) 2015-01-20 2017-06-20 DePuy Synthes Products, Inc. Compositions and methods for treating joints
CN107307422B (zh) * 2017-07-07 2018-09-18 许辉良 速溶石斛提取物及其制备方法
CN107373662B (zh) * 2017-07-07 2020-12-22 江西清源汉本生物科技有限公司 速溶金银花提取物及其制备方法
CN107373663B (zh) * 2017-07-07 2020-12-25 江西清源汉本生物科技有限公司 速溶菊花提取物及其制备方法
CN107595798B (zh) * 2017-09-26 2020-03-24 济川药业集团有限公司 一种琥珀酸普芦卡必利片剂及其制备方法
CN118370693B (zh) * 2024-04-01 2024-10-15 广州梵之容化妆品有限公司 一种分散组合物及其制备方法与应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4678812A (en) * 1986-05-30 1987-07-07 E. I. Du Pont De Nemours And Company Trehalose as stabilizer and tableting excipient
US4762857A (en) * 1986-05-30 1988-08-09 E. I. Du Pont De Nemours And Company Trehalose as stabilizer and tableting excipient
US4712310A (en) * 1986-09-15 1987-12-15 E. I. Du Pont De Nemours And Company Co-spray technique
JP3168550B2 (ja) † 1992-12-02 2001-05-21 株式会社林原生物化学研究所 脱水剤およびそれを用いる含水物の脱水方法並びにその方法で得られる脱水物品
JP3773062B2 (ja) * 1993-01-29 2006-05-10 味の素株式会社 製剤用添加剤
CA2183577C (en) † 1994-03-07 2007-10-30 John S. Patton Methods and compositions for pulmonary delivery of insulin
JP3793590B2 (ja) * 1994-06-27 2006-07-05 株式会社林原生物化学研究所 非還元性糖質とその製造方法並びに用途
EP0693558B1 (de) * 1994-07-19 2002-12-04 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Trehalose, ihre Herstellung und ihre Verwendung
US5556837A (en) † 1994-08-01 1996-09-17 Regeneron Pharmaceuticals Inc. Methods for treating addictive disorders

Also Published As

Publication number Publication date
ATE265205T1 (de) 2004-05-15
CA2245708A1 (en) 1997-08-14
WO1997028788A1 (en) 1997-08-14
AU1729297A (en) 1997-08-28
DE69728857D1 (de) 2004-06-03
EP0879048B2 (de) 2009-07-29
CN1213299A (zh) 1999-04-07
CA2245708C (en) 2008-01-22
EP0879048A1 (de) 1998-11-25
EP0879048B1 (de) 2004-04-28
BR9714509A (pt) 2000-03-21
DE69728857T3 (de) 2010-02-18
JP2000505801A (ja) 2000-05-16

Similar Documents

Publication Publication Date Title
DE69728857T2 (de) Feste arzneimittel enthaltend trehalose
EP1094788A4 (de) Geschmacksmaskierung mittels croscarmellose
ES8501978A1 (es) Un procedimiento para preparar un agente anti-inflamatorio
HUP9900467A2 (hu) Savval szemben labilis, omeprazolt tartalmazó gyógyászati készítmény, és eljárás előállítására
BR0003158A (pt) Formulação de dosagem oral de derretimentoinstantâneo
HUT57796A (en) Process for producing polysaccharide mixtures of small molecular mass and pharmaceutical compositions comprising such active ingredient
EP0096286A3 (de) Hydrolyseempfindlichen Wirkstoff enthaltende, lagerstabile Tablette
KR910014120A (ko) 피모벤단의 경구용 약제학적 제제
CA2124568A1 (en) Method for producing microgranulated particle
ES8400870A1 (es) Un procedimiento para la preparacion de un articulo moldeado solido que comporta una cantidad unitaria predeterminada de un producto quimico.
ATE62408T1 (de) Arzneimittel mit langsamer wirkstofffreisetzung.
EP1211951A4 (de) Verfahren zur herstellung eines pharmazeutischen kaugummis
CA2098667A1 (en) The production of solid pharmaceutical depot forms
PT86186A (en) Process for the preparation of benzimidazol derivatives and of pharmaceutical compositions containing the same
HK218696A (en) Controlled release nifedipine preparations
ES2131318T3 (es) Pelets.
HUP9802498A2 (hu) Eljárás és berendezés hatóanyagoknak valamely szűrőanyagra történő felhordására
KR850005271A (ko) 폴리카프로락톤 매트릭스로 이루어진 경구용 약제의 제조방법
JO2325B1 (en) A pharmaceutical composition with a flavoring taste and a process to prepare it
ATE110267T1 (de) Verfahren zur hestellung von tabletten, die sprühgetrocknetes naproxen oder naproxen natriumsalz enthalten.
DZ3208A1 (fr) Comprimes faiblement doses et procédé de préparation.
UA89349C2 (uk) Таблетка без покриття, яка містить оланзапін, та спосіб її одержання
PL355106A1 (en) Novel dispersible and soluble galenic paracetamol formulation, method for its preparation and its applications
WO1997010810A3 (en) Pharmaceutical granules
JPS5225015A (en) Process for preparing fine granular drugs

Legal Events

Date Code Title Description
8363 Opposition against the patent
8366 Restricted maintained after opposition proceedings
8339 Ceased/non-payment of the annual fee